HMGB1 and COVID-19: Although the current preliminary in vitro studies indicate that HMGB1 has a potential role in COVID-19, novel animal models of SARS-CoV-2 infection will undoubtedly be of great value for further evaluation of the use of HMGB1 inhibitors in the treatment of COVID-19.